In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

ESC TV - Guidelines

News and opinion on the latest ESC Clinical Practice Guidelines

Watch now

Valvular Heart Disease (Management of)

ESC Clinical Practice Guidelines

Non-Invasive Imaging
Non-Coronary Cardiac Intervention
Cardiovascular Surgery
Valvular Heart Diseases
Guidelines version available to download
Published in 2017
Reference VHD
Published in 2017
Reference VHD
App
Published in 2017
Reference Download the Pocket Guidelines App
Published in 2017
Reference Valvular Heart Disease slide-set 2017
Published in 2012
Reference European Heart Journal (2012) 33, 2451–2496; doi:10.1093/eurheartj/ehs109
Table of contents: Full Text (ESC Clinical Practice Guidelines)

1. Preamble
2. Introduction    
  2.1. Why do we need new guidelines on valvular heart disease?    
  2.2. Content of these guidelines    
  2.3. New format of the guidelines    
  2.4 How to use these guidelines    
3. General comments
  3.1 Patient evaluation    
  3.2 Risk stratification    
  3.3 Special considerations in elderly patients    
  3.4 Endocarditis prophylaxis    
  3.5 Prophylaxis for rheumatic fever    
  3.6 Concept of the Heart Team and heart valve centres    
  3.7 Management of associated conditions
4. Aortic regurgitation    
  4.1 Evaluation        
  4.2 Indications for intervention    
  4.3. Medical therapy    
  4.4 Serial testing    
  4.5 Special patient populations    
5. Aortic stenosis    
  5.1 Evaluation    
  5.2 Indications for intervention    
  5.3 Medical therapy    
  5.4 Serial testing    
  5.5 Special patient populations    
6. Mitral regurgitation    37
  6.1 Primary mitral regurgitation    
  6.2 Secondary mitral regurgitation    
7. Mitral stenosis    
  7.1 Evaluation    
  7.2 Indications for intervention    
  7.3 Medical therapy    
  7.4 Serial testing    
  7.5 Special patient populations    
8. Tricuspid regurgitation    
  8.1. Evaluation    
  8.2. Indications for intervention    
9. Tricuspid stenosis    
  9.1 Evaluation    
  9.2 Indications for intervention    
  9.3 Medical therapy    
10. Combined and multiple valve diseases    
11. Prosthetic valves    
  11.1 Choice of prosthetic valve    5
  11.2 Management after valve intervention    
12. Management during non-cardiac surgery    
  12.1 Preoperative evaluation    
  12.2 Specific valve lesions        
  12.3 Perioperative monitoring
13. Management during pregnancy
  13.1 Native valve disease
  13.2 Prosthetic valves
Appendix
References